US Asset Management LLC’s Gilead Sciences GILD Stock Holding History

US Asset Management LLC’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$620K	Buy	4,910 +24	+0.5%	+$3.16K	0.47%	53
2026 Q1	$681K	Sell	4,886 -20	-0.4%	-$2.8K	0.59%	49
2025 Q4	$602K	Sell	4,906 -46	-0.9%	-$5.59K	0.49%	52
2025 Q3	$550K	Sell	4,952 -24	-0.5%	-$2.73K	0.45%	57
2025 Q2	$552K	Sell	4,976 -14	-0.3%	-$1.49K	0.48%	55
2025 Q1	$559K	Sell	4,990 -16	-0.3%	-$1.65K	0.53%	52
2024 Q4	$462K	Sell	5,006 -148	-3%	-$13.3K	0.41%	67
2024 Q3	$477K	Sell	5,154 -69	-1%	-$5.26K	0.42%	71
2024 Q2	$358K	Sell	5,223 -176	-3%	-$11.7K	0.32%	88
2024 Q1	$395K	Sell	5,399 -106	-2%	-$8.15K	0.36%	86
2023 Q4	$446K	Buy	+5,505	New	+$428K	0.44%	70
2023 Q2	$422K	Sell	5,471 -227	-4%	-$18.1K	0.45%	74
2023 Q1	$473K	Sell	5,698 -31	-0.5%	-$2.57K	0.48%	67
2022 Q4	$492K	Buy	+5,729	New	+$454K	0.53%	61
2022 Q2	$355K	Buy	5,743 +24	+0.4%	+$1.49K	0.39%	82
2022 Q1	$340K	Buy	5,719 +36	+0.6%	+$2.3K	0.31%	96
2021 Q4	$413K	Sell	5,683 -4	-0.1%	-$276	0.4%	79
2021 Q3	$397K	Buy	+5,687	New	+$400K	0.38%	81

Other funds holding GILD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

US Asset Management LLC's GILD Position: Q2 2026 in Review

US Asset Management LLC increased its Gilead Sciences (GILD) stake by 0.49% in Q2 2026, buying an estimated $3.16K and bringing the position to 4,910 shares worth $620K. The position accounts for 0.47% of the portfolio, ranked #53.

US Asset Management LLC first reported a position in GILD in Q3 2021 and has held it in 18 quarters since. The position peaked at $681K in Q1 2026. 2,278 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

US Asset Management LLC held 4,910 shares of Gilead Sciences worth $620K as of Q2 2026.
US Asset Management LLC bought 24 Gilead Sciences shares in Q2 2026, an estimated $3.16K.
Gilead Sciences made up 0.47% of US Asset Management LLC's portfolio in Q2 2026, its #53 holding.
US Asset Management LLC first reported a position in Gilead Sciences in Q3 2021 and has held it in 18 quarters since.
US Asset Management LLC's Gilead Sciences position peaked at $681K in Q1 2026.
2,278 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on US Asset Management LLC's 13F filing for Q2 2026, filed 12 Aug 2026.